Thousands of Floridians living with HIV will retain uninterrupted access to their antiretroviral medications beginning Sunday after Florida lawmakers formally reversed proposed cuts to the state's Medicaid drug formulary, according to the AIDS Healthcare Foundation, which led advocacy efforts to block the reductions.

The AIDS Healthcare Foundation confirmed Saturday that emergency coverage provisions would activate June 1, ensuring that an estimated 4,000 to 5,000 patients enrolled in Florida Medicaid who rely on HIV antiretroviral therapy will face no gap in prescription access. The reversal came after intense lobbying by patient advocates, physicians, and AHF representatives who warned that any interruption in antiretroviral coverage could trigger viral rebound and increase transmission risk across the state.

AHF President Michael Weinstein called the outcome a critical victory but cautioned that the legislative session had exposed structural vulnerabilities in how Florida manages drug coverage for its most vulnerable populations. 'We came dangerously close to an entirely preventable public health crisis,' Weinstein said in a statement released late Saturday. 'Today we celebrate, but we must also demand that Florida build in permanent protections against politically motivated formulary changes.'

Florida's Agency for Health Care Administration, which administers the state's Medicaid programme, is expected to issue updated formulary guidance to managed care plans and pharmacies on Sunday, formally notifying providers that the affected HIV medications remain covered without prior authorisation requirements. Advocacy groups have requested that the agency publish a public-facing notice to reduce confusion among patients and pharmacists.

Health policy analysts said the Florida episode would likely reverberate nationally as other states, including Montana, weigh changes to Medicaid eligibility and drug coverage under pressure from federal budget negotiations. The episode underscored the degree to which state-level Medicaid decisions can rapidly affect the health outcomes of populations dependent on continuous medication regimens, with HIV advocates warning they will continue monitoring legislative sessions across the South for similar proposals.